FSPHX
Price
$31.49
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
JFNCX
Price
$65.83
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSPHX vs JFNCX

Header iconFSPHX vs JFNCX Comparison
Open Charts FSPHX vs JFNCXBanner chart's image
Fidelity Select Health Care
Price$31.49
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Janus Henderson Global Life Sciences C
Price$65.83
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSPHX vs JFNCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. JFNCX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongSell and JFNCX is a StrongSell.

FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.41B vs. JFNCX (5.5B). FSPHX (0.00) and JFNCX (0.00) have matching dividends . FSPHX was incepted earlier than JFNCX: FSPHX (43 years) vs JFNCX (15 years). FSPHX is a more actively managed with annual turnover of: 40.00 vs. JFNCX (34.00). FSPHX has a lower initial minimum investment than JFNCX: FSPHX (0) vs JFNCX (2500). FSPHX annual gain was more profitable for investors over the last year : 21.16 vs. JFNCX (18.06). JFNCX return over 5 years is better than : 22.46 vs. FSPHX (19.77).
FSPHXJFNCXFSPHX / JFNCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence43 years15 years-
Gain YTD9.49211.50183%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets7.41B5.5B135%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.1618.06117%
Returns for 3 years-8.78-1.52578%
Returns for 5 years19.7722.4688%
Returns for 10 years40.4427.67146%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIELX8.45N/A
N/A
MassMutual International Eq Adm
DSEFX39.72N/A
N/A
Domini Impact Equity Investor
JGLYX19.28N/A
N/A
JPMorgan Small Cap Growth R4
RFEBX87.35-0.26
-0.30%
American Funds Fundamental Invs R2E
DGECX19.84-0.13
-0.65%
BNY Mellon Global Emerging Mkts - C